alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
From: afrancois@sbcglobal.net

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 3:04:46 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Suzanne Francois

Sacramento, CA 95818
<PAGE>   1
                                                                      EXHIBIT 11




                                 ORBIT/FR,INC.

                STATEMENT RE: COMPUTATION OF EARNINGS PER SHARE
            (AMOUNTS IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)


<TABLE>
<CAPTION>
                                               Three months ended                 Nine months ended 
                                               ------------------                 -----------------
                                                  September 30                       September 30
                                                  ------------                       ------------
                                             1997             1996              1997              1996
                                             ----             ----              ----              ----
                                                   (Unaudited)                       (Unaudited)
                                                   -----------                       -----------
<S>                                        <C>               <C>              <C>               <C>
Net income                                    $1,193              $193           $2,644              $270
                                              ------              ----           ------              ----

Weighted average number of common
   shares outstanding                      6,000,000         4,000,000        4,747,253         4,000,000

Net effect of dilutive stock options--
   using the treasury stock method           280,875                --           99,114                --

Shares to be issued in connection
   with the AEMI acquisition                  83,455                --           31,181                --
                                              ------            ------           ------            ------
                                           6,364,330         4,000,000        4,877,547         4,000,000
                                           ---------         ---------        ---------         ---------

Net income per share                       $    0.19         $    0.05        $    0.54         $    0.07
                                                ----              ----             ----              ----
</TABLE>





                                       17
<TABLE> <S> <C>


<ARTICLE>                     5
<CIK>                         0001036327
<NAME>                        GFSI, INC.
<MULTIPLIER>                                   1,000
<CURRENCY>                                     U.S. DOLLARS


<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              JUN-30-2000
<PERIOD-START>                                 JUL-03-1999
<PERIOD-END>                                   DEC-31-1999
<EXCHANGE-RATE>                                1
<CASH>                                         3,110
<SECURITIES>                                   0
<RECEIVABLES>                                  35,780
<ALLOWANCES>                                   0
<INVENTORY>                                    37,538
<CURRENT-ASSETS>                               79,125
<PP&E>                                         40,529
<DEPRECIATION>                                 20,597
<TOTAL-ASSETS>                                 105,833
<CURRENT-LIABILITIES>                          29,656
<BONDS>                                        174,550
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       0
<OTHER-SE>                                     (93,203)
<TOTAL-LIABILITY-AND-EQUITY>                   105,833
<SALES>                                        106,345
<TOTAL-REVENUES>                               106,345
<CGS>                                          64,446
<TOTAL-COSTS>                                  88,084
<OTHER-EXPENSES>                               (130)
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             8,857
<INCOME-PRETAX>                                9,534
<INCOME-TAX>                                   3,722
<INCOME-CONTINUING>                            5,812
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   5,812
<EPS-BASIC>                                  0
<EPS-DILUTED>                                  0



</TABLE>
#### The People of the State of New York, Respondent, v Dwight Watson, Appellant.

[633 NYS2d 15]

—Judgment, Supreme Court, Bronx County (Richard Lee Price, J.), rendered February 17, 1994, convicting defendant, after a jury trial, of promoting prison contraband in the first degree and assault in the third degree, and sentencing him, as a second felony offender, to concurrent prison terms of 3 to 6 years and 1 year, respectively, unanimously affirmed.

The trial court properly refused defendant’s request for a missing witness charge as to a correction officer who may have been in a position to view the assault. Defendant failed to demonstrate that this uncalled witness viewed anything different from what the testifying officer saw *(People v Ortiz,*83 NY2d 989). The trial court also properly denied a missing witness charge with respect to another correction officer whom defendant claims would have provided testimony concerning the chain of custody of the razor. This witness’s testimony would have been immaterial since the razor was not introduced into evidence, and, in any event, would have constituted hearsay *(People v Small,*201 AD2d 315, 316, *Iv denied*83 NY2d 876). Concur—Murphy, P. J., Sullivan, Rosenberger, Ross and Tom, JJ.
f8k122812a1ex10xxv_cactus.htm


Exhibit 10.25





 


Actinium Pharmaceuticals, Inc.


 


June 19, 2011


 


Sloan-Kettering Institute for Cancer Research


1275 York Avenue 


New York, NY 10021 


Attn: Andrew Maslow


 


Dear Andrew:


 


Following up on our recent discussions I am writing to confirm the agreement between Sloan-Kettering Institute for Cancer Research (SKI) and Actinium Pharmaceutical, Inc. (API) as follows:


 



	
1)     

	
By letter of April 9, 2010 ("Letter") SKI agreed on behalf of itself and certain related parties to forbear and defer collection of certain Obligations (as defined in that letter, a copy of which is attached hereto). Actinium Holdings Limited, an affiliate of SKI owns a majority of the currently issued and outstanding capital stock of API. In order to facilitate the consummation of API's Series E Preferred Stock financing, SKI and its related parties agree to cancel, forgive and release API from all further liability for the Obligations which are set forth in the Letter.







 



	
2)     

	
API agrees to re-affirm its ongoing support of the actinium related research being conducted at SKI and has budgeted the following amounts for the support of that research and maintenance of the intellectual property estate that is licensed to API:







 



	
2011

	
$50,000


	
2012

	
$200,000


	
2013

	
$250,000







 


Please acknowledge your agreement by signing and returning to me a counterpart of this letter agreement (including by fax or email) at which time it will become a binding agreement between us as of the date first written above.


 




	ACTINIUM PHARMACEUTICALS, INC.	 	SLOAN-KETTERING INSTITUTE

FOR CANCE SEARCH

	 
	 	 	 	 	 	 
	By:	 	 	
By: 

	/s/ Andrew D. Maslow	 
	 	Name:	 	 	Name: Andrew D. Maslow	 
	 	Title:	 	 	Title: Director Office of Industrial Affairs
<TABLE> <S> <C>






<ARTICLE>                                    9

  <S>                                         <C>
<PERIOD-TYPE>                                9-MOS
<FISCAL-YEAR-END>                           DEC-31-2000
<PERIOD-END>                                SEP-30-2000
<CASH>                                        3,571,065
<INT-BEARING-DEPOSITS>                          357,715
<FED-FUNDS-SOLD>                                388,000
<TRADING-ASSETS>                                      0
<INVESTMENTS-HELD-FOR-SALE>                  18,508,890
<INVESTMENTS-CARRYING>                                0
<INVESTMENTS-MARKET>                                  0
<LOANS>                                      96,151,453
<ALLOWANCE>                                   1,068,133
<TOTAL-ASSETS>                              123,575,338
<DEPOSITS>                                  106,573,272
<SHORT-TERM>                                  4,432,133
<LIABILITIES-OTHER>                             887,033
<LONG-TERM>                                       9,443
<PREFERRED-MANDATORY>                                 0
<PREFERRED>                                           0
<COMMON>                                        567,512
<OTHER-SE>                                   11,105,945
<TOTAL-LIABILITIES-AND-EQUITY>              123,575,338
<INTEREST-LOAN>                               5,868,841
<INTEREST-INVEST>                               771,713
<INTEREST-OTHER>                                 96,072
<INTEREST-TOTAL>                              6,736,626
<INTEREST-DEPOSIT>                            3,566,539
<INTEREST-EXPENSE>                            3,710,380
<INTEREST-INCOME-NET>                         3,026,246
<LOAN-LOSSES>                                   117,000
<SECURITIES-GAINS>                                    0
<EXPENSE-OTHER>                               2,732,084
<INCOME-PRETAX>                               1,109,628
<INCOME-PRE-EXTRAORDINARY>                    1,109,628
<EXTRAORDINARY>                                       0
<CHANGES>                                             0
<NET-INCOME>                                    839,243
<EPS-BASIC>                                      1.55
<EPS-DILUTED>                                      1.55
<YIELD-ACTUAL>                                     3.67
<LOANS-NON>                                     364,000
<LOANS-PAST>                                  1,002,891
<LOANS-TROUBLED>                                      0
<LOANS-PROBLEM>                                       0
<ALLOWANCE-OPEN>                                895,952
<CHARGE-OFFS>                                    24,367
<RECOVERIES>                                     79,548
<ALLOWANCE-CLOSE>                             1,068,133
<ALLOWANCE-DOMESTIC>                            993,908
<ALLOWANCE-FOREIGN>                                   0
<ALLOWANCE-UNALLOCATED>                          74,225




</TABLE>
EXHIBIT
32.1


CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





Danny
Elbaz   the Chief Executive Officer,  and Director of The
Mobile Star Corp  , certifies, under the standards set forth and
solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Annual Report on
Form 10-K/A of the Registrant for the fiscal year ended December 31, 2009, fully
complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 and information contained in that Form 10-K/A fairly
presents, in all material respects, the financial condition
and  results of operations of the Registrant.





(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and





(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the
Registrant.




Date:
      September 27, 2010
            The
      Mobile Star CorpBy:
            /s/Danny ElbazName:Danny
      Elbaz
              Title:    Chief Executive Officer,
      and  Director




A signed
original of this written statement required by Section 906 has been provided to
the Registrant and will be retained by the Registrant and furnished to the
Securities and Exchange Commission or its staff upon request.
CONSENT OF INDEPENDENT AUDITORS


            We consent to the  incorporation  by reference in Amendment No. 1 to
the  Registration  Statement (Form S-3 No.  333-6131) and related  Prospectus of
Cover-All  Technologies  Inc. for the  registration  of 6,591,528  shares of its
common stock of our report  dated April 11,  1997,  with respect to the 1996 and
1995 consolidated  financial  statements and schedule of Cover-All  Technologies
Inc.  included in this Annual Report (Form 10-K) for the year ended December 31,
1997.

            We  also   consent  to  the   incorporation   by  reference  in  the
Registration  Statement (Form S-8 No. 33-18243) pertaining to the 1982 Incentive
Stock  Option Plan and in the  Registration  Statement  (Form S-8 No.  33-44270)
pertaining  to the 1991 Key Employee  Stock Option Plan,  the 1988  Non-Employee
Director Stock Option Plan and certain Non-Qualified Stock Option Contracts, and
in the related  Prospectuses of Cover-All  Technologies Inc. of our report dated
April  11,  1997,  with  respect  to the 1996 and  1995  consolidated  financial
statements and schedule of Cover-All  Technologies  Inc. included in this Annual
Report (Form 10-K) for the year ended December 31, 1997.





                                    ERNST & YOUNG LLP




Hackensack, New Jersey
March 30, 1998
Exhibit 32.1

CERTIFICATION BY CHIEF EXECUTIVE OFFICER AND ACTING CHIEF FINANCIAL OFFICER

Pursuant to 18 U.S.C.
Section 1350, As Adopted Pursuant

To Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. § 1350, the undersigned officer of Intelsat Corporation (the Company) hereby certifies that to such officers
knowledge, the Companys Quarterly Report on Form 10-Q for the quarter ended September 30, 2008 (the Report) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of
1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                        |  |  |  |                                                           
|----------------------- |  |  |  | ----------------------------------------------------------
|Date: November 13, 2008 |  |  |  | /s/ DAVID MCGLADE                                         
|                        |  |  |  | David McGlade                                             
|                        |  |  |  | Chief Executive Officer and Acting Chief Financial Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not
being filed as part of the Report or as a separate disclosure document.
**Exhibit 32.1**

**CERTIFICATION PURSUANT TO 18 USC, SECTION 1350,**				 **AS ADOPTED PURSUANT TO SECTION 906**				 **OF THE SARBANES-OXLEY ACT OF 2002**

          In connection with the Quarterly Report of Material Technologies, Inc. (the “Company”) on Form 10-QSB for the quarter ended March 31, 2007, as filed with the Securities and Exchange Commission on or about the date hereof (the “Report”), I, Robert M. Bernstein, President of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:				          (1)       The Report fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934; and				          (2)       Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

| Dated:  May 21, 2007 | /s/ Robert M. Bernstein                     |
|---------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------|
|                           | By:  Robert M. Bernstein                                                                                                                   |
|                           | Its:  President                                                                                                                            |

----
Exhibit
      32.1








CERTIFICATION
OF CHIEF EXECUTIVE OFFICER


PURSUANT
TO 18 UNITED STATES CODE SS. 1350





In connection with the Quarterly Report
of Griffin Land & Nurseries, Inc. (the “Company”) on Form 10-Q for the
quarter ended March 1, 2008 as filed with the Securities and Exchange Commission
on the date hereof (the “Periodic Report”), I, Frederick M. Danziger, President
and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:





1.
            The
      Periodic Report fully complies with the requirements of Section 13(a) or
      15(d), as applicable, of the Securities Exchange Act of 1934, as amended;
      and





2.
            The
      information contained in the Periodic Report fairly presents, in all
      material respects, the financial condition and results of operations of
      the Company.











/s/ FREDERICK M.
      DANZIGERFrederick
      M. DanzigerPresident
      and Chief Executive OfficerApril
      10, 2008
From: gmiller1932@comcast.net

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 3:01:40 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

William Miller

Franklin, TN 37067